Search for: "Amphastar Pharmaceuticals v. Aventis Pharma"
Results 1 - 20
of 22
Sorted by Relevance
|
Sort by Date
26 May 2008, 9:48 pm
RE 38,743 and 5,389,618, which are owned by Plaintiffs-Appellees Aventis Pharma S.A. and Aventis Pharmaceuticals, Inc. [read post]
26 May 2008, 9:48 pm
RE 38,743 and 5,389,618, which are owned by Plaintiffs-Appellees Aventis Pharma S.A. and Aventis Pharmaceuticals, Inc. [read post]
29 Jan 2009, 3:48 am
Aventis Pharma v. [read post]
29 Jan 2009, 9:59 pm
Amphastar Pharmaceuticals, regarding the standard for finding inequitable conduct. [read post]
11 Feb 2007, 8:27 pm
Aventis Pharma v. [read post]
12 Sep 2021, 9:59 pm
Noonan -- Imposition of liability under the equitable doctrine of inequitable conduct (as it has been variously defined) can result in a patent being held unenforceable; for this reason, former Chief Judge Rader called it the "atomic bomb of patent law" (see Aventis Pharma S.A. v. [read post]
3 Apr 2019, 5:15 am
Amphastar Pharmaceutical, Inc.,... [read post]
9 Jun 2008, 8:33 pm
Aventis Pharma v. [read post]
30 Jan 2009, 9:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: AIPLA urges Federal Circuit not to proscribe patents for biomedical diagnostic tools: Prometheus v Mayo (Inventive Step) (Hal Wegner) (Patently-O) (Holman's Biotech IP Blog) Lovenox (Enoxaparin) – US: Aventis files for certiorari: challenging Federal Circuit’s low standard for intent to deceive in… [read post]
3 Apr 2019, 5:15 am
Amphastar Pharmaceutical, Inc., 525 F.3d 1334, 1349 (Fed.Cir.2008). [read post]
27 May 2013, 7:22 pm
See Pharmaceuticals v. [read post]
1 May 2009, 9:00 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
6 Feb 2009, 5:00 am
(IP finance) Pharmaceutical Technology article on barriers to entry for generic pharma companies based in emerging economies (Afro-IP) The effects of IP protection on agricultural research: Patents are not the problem – response to Nature Biotechnology article ‘Patents Versus Patenting: Implications of Intellectual Property Protection for Biological Research’ (Patent Docs) SPC seminar – a brief report (The SPC Blog) (The SPC Blog) Ruminations… [read post]
20 Apr 2009, 2:24 pm
Opinion below (3rd Circuit) Petition for certiorari Brief in opposition Petitioner's reply Docket: 08-937 Title: Aventis Pharma S.A., et al., Petitioners v. [read post]
27 Feb 2009, 5:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Evista (Raloxifene) – US: CAFC affirms extension of 30-month stay against Teva’s generic Evista: Eli Lilly & Co v Teva Pharmas. [read post]
4 Jan 2013, 7:03 am
Aventis Pharma S.A. v. [read post]
1 Dec 2007, 9:00 am
(UK Channel Management Ltd v E! [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation amendments to dodge real… [read post]
30 May 2008, 9:09 am
: (Spicy IP), India: DCGI preparing document to implement patent-registration linkage: (Spicy IP), New Zealand: Generic pharmaceutical companies taking advantage of NZ IP laws and medicines regulations: (International Law Office), Uganda: Cipla licenses ARV technology into Uganda: (Afro-IP), US: Money saved through generic prescriptions: (GenericsWeb), US: Government plans to keep close tab on drug patent settlements: (GenericsWeb), US: FTC reports 14 deals to delay generics in 2007:… [read post]
23 May 2008, 1:03 am
– Brdo: (IPR-Helpdesk), 5-6 June: USFDA public meeting on evaluation of product trade names: (FDA Law Blog), 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: MARQUES ‘First meeting with Spanish Judges of the Community Trade Mark Courts’ – Alicante: (Class 46), 16 June / 1 July: US PLI: ‘Prior art & obviousness 2008: The PTO and CAFC perspective on patent law sections 102 & 103’ -… [read post]
